Inclusion of ibuprofen in mesoporous templated silica:: drug loading and release property

被引:447
作者
Charnay, C [1 ]
Bégu, S [1 ]
Tourné-Péteilh, C [1 ]
Nicole, L [1 ]
Lerner, DA [1 ]
Devoisselle, JM [1 ]
机构
[1] ENSCM, UMR,UMI 5618, CNRS, Lab Mat Catalyt & Catalyse Chim Organ, F-34296 Montpellier 5, France
关键词
drug loading; mesoporous silica; MCM; 41; ibuprofen;
D O I
10.1016/j.ejpb.2003.12.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study is to determine the feasibility of loading biologically active molecules into templated mesoporous silica (MCM 41). This material shows an important mesoporosity associated to hexagonally organized channels, a narrow pore size distribution and a large surface area. Ibuprofen was selected as a model molecule since it is a well documented and much used anti-inflammatory drug. Furthermore, it has a lipophilic character and its molecular size is suitable for inclusion within the mesopores of the MCM 41 material. In order to load ibuprofen within the mesopores, adsorption experiments using various solvents or successive impregnations with solutions of ibuprofen in ethanol were performed. At each step of the loading process, the pore filling was characterized by nitrogen adsorption experiments and by X-ray diffraction. The impregnation procedure results in a significant improvement of the amount of ibuprofen loaded into MCM 41. The in vitro drug release was investigated with simulated biological fluids (gastric and intestinal). Hundred percent release is observed at the end of the in vitro experiment. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 28 条
  • [1] Silica xerogel carrier material for controlled release of toremifene citrate
    Ahola, M
    Kortesuo, P
    Kangasniemi, I
    Kiesvaara, J
    Yli-Urpo, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) : 219 - 227
  • [2] Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents - I. Intercalation and in vitro release of ibuprofen
    Ambrogi, V
    Fardella, G
    Grandolini, G
    Perioli, L
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 220 (1-2) : 23 - 32
  • [3] Benita S., 1996, MICROENCAPSULATION D
  • [4] Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus
    Bhattachar, SN
    Wesley, JA
    Fioritto, A
    Martin, PJ
    Babu, SR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 236 (1-2) : 135 - 143
  • [5] Preferential grafting of alkoxysilane coupling agents on the hydrophobic portion of the surface of micelle-templated silica
    Brunel, D
    Cauvel, A
    Di Renzo, F
    Fajula, F
    Fubini, B
    Onida, B
    Garrone, E
    [J]. NEW JOURNAL OF CHEMISTRY, 2000, 24 (10) : 807 - 813
  • [6] Ordered mesoporous materials
    Ciesla, U
    Schüth, F
    [J]. MICROPOROUS AND MESOPOROUS MATERIALS, 1999, 27 (2-3) : 131 - 149
  • [7] INVIVO EVALUATION OF RAPID RELEASE AND SUSTAINED-RELEASE GELUCIRE CAPSULE FORMULATIONS
    DENNIS, AB
    FARR, SJ
    KELLAWAY, IW
    TAYLOR, G
    DAVIDSON, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (1-2) : 85 - 100
  • [8] Derrien A, 1998, STUD SURF SCI CATAL, V117, P445
  • [9] A 28-year-old synthesis of micelle-templated mesoporous silica
    DiRenzo, F
    Cambon, H
    Dutartre, R
    [J]. MICROPOROUS MATERIALS, 1997, 10 (4-6): : 283 - 286
  • [10] LIPID-COMPOSITION AND STRUCTURE OF COMMERCIAL PARENTERAL EMULSIONS
    FEREZOU, J
    LAI, NT
    LERAY, C
    HAJRI, T
    FREY, A
    CABARET, Y
    COURTIEU, J
    LUTTON, C
    BACH, AC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994, 1213 (02): : 149 - 158